globalchange  > 气候变化与战略
DOI: 10.1073/pnas.1907631116
论文题名:
Phase variation in Mycobacterium tuberculosis glpK produces transiently heritable drug tolerance
作者: Safi H.; Gopal P.; Lingaraju S.; Ma S.; Levine C.; Dartois V.; Yee M.; Li L.; Blanc L.; Liang H.-P.H.; Husain S.; Hoque M.; Soteropoulos P.; Rustad T.; Sherman D.R.; Dick T.; Alland D.
刊名: Proceedings of the National Academy of Sciences of the United States of America
ISSN: 0027-8424
出版年: 2019
卷: 116, 期:39
起始页码: 19665
结束页码: 19674
语种: 英语
英文关键词: GlpK ; Mycobacterium tuberculosis ; Phase variation ; Reversible drug tolerance ; Small colony variant
Scopus关键词: cytosine ; ethambutol ; isoniazid ; moxifloxacin ; rifampicin ; animal experiment ; animal model ; animal tissue ; antibiotic sensitivity ; Article ; bacterial gene ; controlled study ; dosR gene ; drug tolerance ; female ; frameshift mutation ; gene deletion ; gene insertion ; gene repression ; genetic association ; glpK gene ; in vitro study ; kstR gene ; lung tuberculosis ; minimum inhibitory concentration ; mouse ; Mycobacterium tuberculosis ; nonhuman ; phenotype ; priority journal ; regulon ; sigH gene ; treatment duration
英文摘要: The length and complexity of tuberculosis (TB) therapy, as well as the propensity of Mycobacterium tuberculosis to develop drug resistance, are major barriers to global TB control efforts. M. tuberculosis is known to have the ability to enter into a drug-tolerant state, which may explain many of these impediments to TB treatment. We have identified a mechanism of genetically encoded but rapidly reversible drug tolerance in M. tuberculosis caused by transient frameshift mutations in a homopolymeric tract (HT) of 7 cytosines (7C) in the glpK gene. Inactivating frameshift mutations associated with the 7C HT in glpK produce small colonies that exhibit heritable multidrug increases in minimal inhibitory concentrations and decreases in drug-dependent killing; however, reversion back to a fully drug-susceptible large-colony phenotype occurs rapidly through the introduction of additional insertions or deletions in the same glpK HT region. These reversible frameshift mutations in the 7CHT of M. tuberculosis glpK occur in clinical isolates, accumulate in M. tuberculosis-infected mice with further accumulation during drug treatment, and exhibit a reversible transcriptional profile including induction of dosR and sigH and repression of kstR regulons, similar to that observed in other in vitro models of M. tuberculosis tolerance. These results suggest that GlpK phase variation may contribute to drug tolerance, treatment failure, and relapse in human TB. Drugs effective against phase-variant M. tuberculosis may hasten TB treatment and improve cure rates. © 2019 National Academy of Sciences. All rights reserved.
Citation statistics:
资源类型: 期刊论文
标识符: http://119.78.100.158/handle/2HF3EXSE/163532
Appears in Collections:气候变化与战略

Files in This Item:

There are no files associated with this item.


作者单位: Safi, H., Center for Emerging Pathogens, New Jersey Medical School, Rutgers University, Newark, NJ 07103, United States, Department of Medicine, New Jersey Medical School, Rutgers University, Newark, NJ 07103, United States; Gopal, P., Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117597, Singapore, MSD Translational Medicine Research Centre, MSD International GMBH, Singapore, 637766, Singapore; Lingaraju, S., Center for Emerging Pathogens, New Jersey Medical School, Rutgers University, Newark, NJ 07103, United States, Department of Medicine, New Jersey Medical School, Rutgers University, Newark, NJ 07103, United States; Ma, S., Center for Infectious Disease, Seattle Children's Hospital, Seattle, WA 98105, United States; Levine, C., Center for Emerging Pathogens, New Jersey Medical School, Rutgers University, Newark, NJ 07103, United States, Department of Medicine, New Jersey Medical School, Rutgers University, Newark, NJ 07103, United States; Dartois, V., Public Health Research Institute, New Jersey Medical School, Rutgers University, Newark, NJ 07103, United States, Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ 07110, United States; Yee, M., Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117597, Singapore; Li, L., Public Health Research Institute, New Jersey Medical School, Rutgers University, Newark, NJ 07103, United States, Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ 07110, United States; Blanc, L., Public Health Research Institute, New Jersey Medical School, Rutgers University, Newark, NJ 07103, United States, Institut de Chimie and Biologie des Membranes and des Nano-objets, CNRS, Bordeaux, 33600, France; Liang, H.-P.H., Public Health Research Institute, New Jersey Medical School, Rutgers University, Newark, NJ 07103, United States, Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ 07110, United States; Husain, S., Genomics Center, New Jersey Medical School, Rutgers University, Newark, NJ 07103, United States; Hoque, M., Genomics Center, New Jersey Medical School, Rutgers University, Newark, NJ 07103, United States; Soteropoulos, P., Genomics Center, New Jersey Medical School, Rutgers University, Newark, NJ 07103, United States; Rustad, T., Center for Infectious Disease, Seattle Children's Hospital, Seattle, WA 98105, United States; Sherman, D.R., Center for Infectious Disease, Seattle Children's Hospital, Seattle, WA 98105, United States, Department of Microbiology, University of Washington School of Medicine, Seattle, WA 98195, United States; Dick, T., Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ 07110, United States; Alland, D., Center for Emerging Pathogens, New Jersey Medical School, Rutgers University, Newark, NJ 07103, United States, Department of Medicine, New Jersey Medical School, Rutgers University, Newark, NJ 07103, United States

Recommended Citation:
Safi H.,Gopal P.,Lingaraju S.,et al. Phase variation in Mycobacterium tuberculosis glpK produces transiently heritable drug tolerance[J]. Proceedings of the National Academy of Sciences of the United States of America,2019-01-01,116(39)
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Safi H.]'s Articles
[Gopal P.]'s Articles
[Lingaraju S.]'s Articles
百度学术
Similar articles in Baidu Scholar
[Safi H.]'s Articles
[Gopal P.]'s Articles
[Lingaraju S.]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Safi H.]‘s Articles
[Gopal P.]‘s Articles
[Lingaraju S.]‘s Articles
Related Copyright Policies
Null
收藏/分享
所有评论 (0)
暂无评论
 

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.